Velychko L. Immunocorrection with (2b-interferon is the optimization element therapy of patients with uveal melanoma

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0400U000776

Thesis Registration Form

0400U000776.pdf

Applicant for

Specialization

  • 14.01.07 - Онкологія

22-03-2000

Specialized Academic Board

Д 26.155.01

R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology National Academy of Sciences of Ukraine

Essay

The thesis is devoted to reveal the effectivity of recombinant (2b-interferon - laferon (IFN) inclusion in traditional schedule of therapy of patients with uveal melanoma. Immunocorrection as the result of complex therapy with IFN inclusion was followed by significant decreasing of patient percent with progressive tumor growth and increasing the rate of tumor resorption, and prevents the complications like glaucoma and uveitis also.

Read more

Similar theses

0523U100184

Vyacheslav Maksymovskyi

Optimization of combined treatment of patients with peritoneal carcinomatosis and other intra-abdominal metastases of different primary origin

0523U100072

Vitruk Yuriy

Optimization of Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Renal Cell Carcinoma

0423U100001

Samokhvalova Olena O.

Clinical features and molecular biochemical factors for the prognosis of vulvar cancer recurrence

0521U101888

Stakhovsky Olexander E.

Combined treatment optimization in muscle-invasive bladder cancer

0521U101889

Lyashenko Andrij O.

Complex treatment of patients with inflammatory breast cancer